Egypt, Israel And Turkey: APAC’s Most Vibrant Domestic Injectable Drugs Market

Posted on 2018-08-16 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Aug-16 — /EPR Network/ —According to Goldstein Research, Asia-Pacific region is expected to be the fastest growing region in the injectable drug market over the forecast period. Asia-Pacific region is expected to reach the value of USD 133.5 billion by the end of 2024, growing at a CAGR of 10.51 % over the forecast period owing to growing penetration of self-injection technology in Japan, Singapore & China. Latin America & Middle East & Africa together held 7.0% market share in global injectable drug market in 2016. Saudi Arabia, Israel, Mexico, Brazil & Argentina are estimated to gain favorable opportunities for injectable drugs in the forecast years. On the basis of market players, in the US, Pfizer leads in sales revenues of about USD 45 billion USD in 2013 while Johnson & Johnson realized revenue of USD 70,074 million USD in 2015. In Switzerland, Novartis made USD 47,101 million in revenues in 2014 while Roche realized USD 39,120 million USD in the same year. In France, Sanofi made USD 36,437 million USD in 2014 while in Japan, Takeda made USD 20,446 million USD in 2014. Bayer in Germany made USD 15,486 million USD in 2014 in pharmaceuticals.

“Global Injectable Drugs Market Outlook, 2016-2024” covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in the healthcare industry. The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry injectable drugs manufacturers, suppliers, and distributors, pharmaceutical & biotechnology companies, cosmetic product manufacturers, healthcare institutions, clinical centers, medical research laboratories and academic medical centers and universities to analyze the future prospects of the overall healthcare industry.

Global Injectable Drugs Market Segmentation can be classified on the basis of:

By Product Type

Vaccines
Insulin
Conventional Therapeutics
Complex Biologics

By Application

Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others

By Geography

North America (US, Canada) Injectable Drugs Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) Injectable Drugs Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) Injectable Drugs Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Latin America (Brazil, Mexico and Rest of Latin America) Injectable Drugs Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) Injectable Drugs Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-injectable-drugs-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Trends, Drivers & Challenges

Emerging trend in biologic medicine is positively impacting injectable drugs market and acquisition & collaboration plays an important role in enabling business opportunities for injectable drugs. For instance, In July 2016, Lupin pharmaceutical acquired two medical companies of New Jersey worth USD 900 million. In the same year, InvaGen Pharmaceutical was acquired by Cipla for USD 550 million. In October 2016, India based company Piramal announced to buy 5 drugs for pain and anesthetic management from Johnson & Johnson by paying USD 155 million. Piramal holds a significant presence in global generic injectable drug market which valued USD 20 billion in 2016. These acquisitions and partnerships are expected to drive the growth of injectable drugs market during the time period of 2016-2024. However, risk of re-operation or death, safety concerns of injectable drugs and less patient compliance is restraining the expansion of injectable drugs market.

“Global Injectable Drugs Market Report” has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global injectable drugs market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

By Product Type

By Application

By Geography

About Goldstein Research

Matched content

Editor’s pick